We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00117351
Recruitment Status : Terminated (insufficient efficacy)
First Posted : July 6, 2005
Last Update Posted : February 17, 2011
Information provided by:
Millennium Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2007
  Study Completion Date : July 2007